SCHEMBL23458029

SCHEMBL23458029

Cc1ccccc1/C=C/C=C/c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.61
RAB9A P51151 4/20 0.52
KDM4E B2RXH2 1/20 0.52
APOBEC3A P31941 1/20 0.52
APOBEC3G Q9HC16 1/20 0.52
TRPA1 O75762 3/20 0.47
NFE2L2 Q16236 2/20 0.47
ALDH1A1 P00352 2/20 0.46
ALOX5 P09917 2/20 0.46
TSHR P16473 2/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 1/20 0.46
CHAT P28329 2/20 0.46
TTR P02766 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
CYP3A4 P08684 1/20 0.42
MEN1 O00255 1/20 0.42
PABPC1 P11940 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9511790 1.00 MAOB (0.61) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23458030 1.00 MAOB (0.61) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23457956 0.98 MAOB (0.58) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23457957 0.98 MAOB (0.58) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23457968 0.89 ALDH1A1 (0.56) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23458039 0.89 ALDH1A1 (0.56) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL1976903 0.89 ALDH1A1 (0.56) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23457969 0.89 ALDH1A1 (0.56) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL23458040 0.89 ALDH1A1 (0.56) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G
SCHEMBL10768622 0.88 NFE2L2 (0.52) MAOBRAB9AKDM4EAPOBEC3AAPOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons SICPA HOLDING SA (CH) 2025-12-30 US disclosed
EP-4069806-B1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2025-04-16 EP disclosed
US-20240327736-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2024-10-03 US disclosed
EP-4069807-B1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-10-04 EP disclosed
CN-114195610-B Synthesis method of E-type internal olefin compound 海南大学 2023-07-14 CN disclosed
US-20230103579-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2023-04-06 US disclosed
EP-4069807-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS Sicpa Holding SA (CH) 2022-10-12 EP disclosed
EP-4069806-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON Sicpa Holding SA (CH) 2022-10-12 EP disclosed
CN-114195610-A Synthetic method of E-type internal olefin compound 海南大学 2022-03-18 CN disclosed
WO-2021110526-A1 METHOD OF MARKING A PETROLEUM HYDROCARBON SICPA HOLDING SA (CH) 2021-06-10 WO disclosed
WO-2021110525-A1 METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS SICPA HOLDING SA (CH) 2021-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12510529-B2 Method for determining authenticity and adulteration of marked petroleum hydrocarbons CYP4A11, CYP11B1, CYP11A1 MAOB 1867/4885RAB9A 3261/4885KDM4E 1686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.